• English
  • 简体
  • 繁體中文
  • 日本語
General Contact
  • About
    • Company
    • Vision & Mission
    • What We Do
    • Leadership Team
    • About JSR Life Sciences
    • Scientific Advisors
    • Strategic Partners
    • Careers
    • News
  • CVMD
    • Menu Column 1
      • Cardiovascular Disease
        • NHP Models
        • Rodent Models
      • Diabetes
        • NHP Models
        • Rodent Models
      • Obesity
        • NHP Models
        • Rodent Models
    • Menu Column 2
      • NAFLD/NASH
        • NHP Models
        • MS-NASH (FATZO)
      • Liver Fibrosis
        • Rodent Models
      • Renal Disease
        • NHP Models
        • Rodent Models
    • Menu Column 3
      • Safety/Toxicology
        • Bioanalysis
        • Clinical Chemistry and Biomarkers
        • In Vivo PK/PD
        • Non-GLP Toxicology
        • Safety Pharmacology
      • Biomarker Assay Services
        • Cytokine and Chemokine Profiling
        • Flow Cytometry
        • Genomics Services
        • Histology and Digital Pathology
        • Rare Cell Analysis
  • Oncology
    • Menu Column 1
      • In Vivo Services
        • Breast Cancer Preclinical Models
        • Cell Line Derived Xenograft Models
        • Custom Tumor Model Development
        • Immuno-Oncology Models
        • MuScreen
        • Orthotopic and Bioluminescent Models
        • Patient-Derived Xenograft Models (HuPrime/HuKemia)
        • Prostate Cancer Preclinical Models
        • Radiation Therapy
        • Syngeneic Tumor Models
    • Menu Column 2
      • In Vitro Services
        • Cell Based Screening
          • CrownSyn
        • Cell Line Panels
        • Flow Cytometry Platform
        • Immuno-Oncology
        • OmniScreen Cell Based Screening Service
        • Organoids
        • PDX-Derived Cell Lines
      • Organoids
        • Organoid and Immune
          Cell Co-Culture
      • Ex Vivo Services
        • 3D Assays
        • Tumor Microarrays
    • Menu Column 3
      • Immuno-Oncology
        • CAR-T Cell Therapy Models
        • Humanized Models
          • Hematopoietic Stem Cell (HSC)-PDX
          • MiXeno
        • Human Target Knock-In Models
          • HuGEMM
          • HuCELL
        • Murine Immunity Models and Services
          • Tumor Homograft Models
          • Syngeneic Tumor Models
          • MuScreen
      • Translational Oncology
        • Biomarkers of Response (HuMark)
        • Mouse Clinical Trials (HuTrial)
        • Signatures of Response (HuSignature)
    • Menu Column 4
      • Biomarker Assay Services
        • Cytokine and Chemokine Profiling
        • Flow Cytometry
        • Genomics Services
        • Histology and Digital Pathology
        • Rare Cell Analysis
      • Bioinformatics
        • CrownSyn
      • Pharmacology and Bioanalytical Services
        • ADME & Physicochem
        • Bioanalysis Studies
        • In Vivo PK/PD
        • NHP Immuno-Safety
        • Structural Biology
        • Target Validation
      • Oncology Databases
        • HuBase
        • OrganoidBase
        • MuBase
        • OncoExpress
        • XenoBase
  • Inflammation
    • Menu Column 1
      • In Vivo Models
        • Inflammatory Bowel Disease (IBD)
        • Rheumatoid Arthritis (RA)
    • Menu Column 2
      • Biomarker Assay Services
        • Cytokine and Chemokine Profiling
        • Flow Cytometry
        • Genomics Services
        • Histology and Digital Pathology
        • Rare Cell Analysis
crownbio-logo.png
  • Models
    • Cell Line Derived Xenograft
    • HSC and PBMC Humanized
    • Human Target Knock-In ( HuGEMMTM )
    • Patient-Derived Xenograft ( HuPrimeTM )
    • Syngeneic
    • Tumor Homograft ( MuPrimeTM )
  • Resources
  • Blog
  • Databases
    • OncoExpress
    • HuBase
    • XenoBase
    • MuBase
crownbio-logo-xs.png
  • Site Search 360
  • Call
  • Email
  • About
    • Company
    • Vision & Mission
    • What We Do
    • Leadership Team
    • Scientific Advisors
    • Strategic Partners
    • Careers
    • News
  • CVMD
    • Cardiovascular Disease
      • NHP Models
      • Rodent Models
    • Diabetes
      • NHP Models
      • Rodent Models
    • Obesity
      • NHP Models
      • Rodent Models
    • NAFLD/NASH
      • NHP Models
      • MS-NASH (FATZO)
    • Liver Fibrosis
      • Rodent Models
    • Renal Disease
      • NHP Models
      • Rodent Models
    • Safety/Toxicology
      • Bioanalysis
      • Clinical Chemistry and Biomarkers
      • In Vivo PK/PD
      • Non-GLP Toxicology
      • Safety Pharmacology
  • Oncology
    • In Vivo Services
      • Breast Cancer Preclinical Models
      • Cell Line Derived Xenograft Models
      • Custom Tumor Model Development
      • Immuno-Oncology Models
      • MuScreen
      • Orthotopic and Bioluminescent Models
      • Patient-Derived Xenograft Models
      • Prostate Cancer Preclinical Models
      • Radiation Therapy
      • Syngeneic Tumor Models
    • In Vitro Services
      • Cell Based Screening
        • CrownSyn
      • Cell Line Panels
      • Flow Cytometry Platform
      • Immuno-Oncology
      • OmniScreen Cell Based Screening Service
      • Organoids
      • PDX Derived Cell Lines
    • Organoids
      • Organoid and Immune Cell Co-Culture
    • Ex Vivo Services
      • 3D Assays
      • Tumor Microarrays
    • Immuno-Oncology
      • CAR-T Cell Therapy Models
        • Cell Line Derived Xenografts Targeting CD19
        • PDX
      • Humanized Models
        • Hematopoietic stem cell (HSC)-PDX
        • HuGEMM
        • HuCELL
        • MiXeno
      • Murine Immunity Models and Services
        • Tumor Homograft Models
        • Syngeneic Tumor Models
        • MuScreen
    • Biomarker Services
      • Flow Cytometry Platform
      • Histology and Digital Pathology Platform
    • Pharmacology and Bioanalytical Services
      • ADME & Physiochem
      • Bioanalysis Studies
      • Flow Cytometry Platform
      • In Vivo PK/PD
      • NHP Immuno-Safety
      • Structural Biology
      • Target Validation
    • Oncology Databases
      • HuBase
      • MuBase
      • OncoExpress
      • XenoBase
  • Oncology
    • Immuno-Oncology
      • CAR-T Cell Therapy Models
        • Cell Line Derived Xenografts Targeting CD19
        • PDX
      • Humanized Models
        • Hematopoietic stem cell (HSC)-PDX
        • HuGEMM
        • HuCELL
        • MiXeno
      • Murine Efficacy/PD Models
        • Tumor Homograft Models
        • Syngeneic Tumor Models
      • MuScreen
    • In Vitro Services
      • Cell Based Screening
        • CrownSyn
      • Cell Line Panels
      • FACS Platform
      • Immuno-Oncology
      • OmniScreen Cell Based Screening Service
      • PDX Derived Cell Lines
      • Custom Cell Lines
    • In Vivo Services
      • Breast Cancer Preclinical Models
      • Cell Line Derived Xenograft Models
      • Custom Tumor Model Development
      • Immuno-Oncology Models
      • MuScreen
      • Optical Imaging Platforms for Advanced Preclinical Modeling
      • Patient-Derived Xenograft Models
      • Prostate Cancer Preclinical Models
      • Radiation Therapy
      • Syngeneic Tumor Models
    • Ex Vivo Services
      • 3D Assays
      • Tumor Microarrays
    • Oncology Databases
      • HuBase
      • MuBase
      • OncoExpress
      • XenoBase
    • Pharmacology and Bioanalytical Services
      • ADME & Physiochem
      • Bioanalysis Studies
      • FACS Platform
      • In Vivo PK/PD
      • Structural Biology
      • Target Validation
  • Inflammation
    • In Vivo Models
      • Inflammatory Bowel Disease
      • Rheumatoid Arthritis (RA)
    • Biomarker Servicers
      • Flow Cytometry Platform
      • Histology and Digital Pathology Platform
  • Inflammation
    • Inflammatory Bowel Disease (IBD)
    • Rheumatoid Arthritis (RA)
  • Models
    • Cell Line Derived Xenograft
    • HSC and PBMC Humanized
    • Human Target Knock-In ( HuGEMMTM )
    • Patient-Derived Xenograft ( HuPrimeTM )
    • Syngeneic
    • Tumor Homograft ( MuPrimeTM )
  • Resources
    • Posters
    • Publications
    • Presentations
    • White Papers
    • On-Demand Webinars
    • Events
    • Quick Facts
    • FactSheets
    • Application Notes
  • Blog
  • Databases
    • OncoExpress
    • HuBase
    • XenoBase
    • MuBase
  • Contact

Patient-Derived Xenografts (PDX)

Models » PDX

x

Patient-Derived Xenografts (PDX) Models

  • Acute Lymphoblastic LeukemiaAcute Lymphoblastic Leukemia
  • Acute Myeloid LeukemiaAcute Myeloid Leukemia
  • Adrenal Gland CancerAdrenal Gland Cancer
  • Bladder CancerBladder Cancer
  • Brain CancerBrain Cancer
  • Breast CancerBreast Cancer
  • Cervical CancerCervical Cancer
  • CholangiocarcinomaCholangiocarcinoma
  • Colorectal CancerColorectal Cancer
  • Esophageal CancerEsophageal Cancer
  • Gallbladder CancerGallbladder Cancer
  • Gastric CancerGastric Cancer
  • GISTGIST
  • Head and Neck CancerHead and Neck Cancer
  • Kidney CancerKidney Cancer
  • Liver CancerLiver Cancer
  • Lung CancerLung Cancer
  • LymphomaLymphoma
  • MelanomaMelanoma
  • MesotheliomaMesothelioma
  • Metastatic CarcinomaMetastatic Carcinoma
  • Mixed Mullerian CancerMixed Mullerian Cancer
  • Ovarian CancerOvarian Cancer
  • Pancreatic CancerPancreatic Cancer
  • Prostate CancerProstate Cancer
  • SarcomaSarcoma
  • Testical CancerTestical Cancer
  • Thyroid CancerThyroid Cancer
  • Uterine CancerUterine Cancer

Create HuBase Account to View All Model Data

Already Registered? Login

Corporate

  • About Us
  • Careers
  • Investors - Investor relations
  • Leadership Team
  • Scientific Advisors
  • Strategic Partners
  • Vision & Mission
  • What we do
  • News
  • Resources
  • Blog

Models

  • Cell Line Derived Xenograft
  • HSC and PBMC Humanized
  • Human Target Knock-In ( HuGEMMTM )
  • Patient-Derived Xenograft ( HuPrimeTM )
  • Syngeneic
  • Tumor Homograft ( MuPrimeTM )

Inflammation

In Vivo Models

  • Inflammatory Bowel Disease (IBD)
  • Rheumatoid Arthritis (RA)

Biomarker Services

  • Flow Cytometry Platform
  • Histology and Digital Pathology Platform

CVMD

Home

Cardiovascular Disease

  • NHP
  • Rodent

Diabetes

  • NHP
  • Rodent

NAFLD/NASH

  • NHP
  • FATZO

Obesity

  • NHP
  • Rodent

Renal Disease

  • NHP
  • Rodent

Safety/Toxicology

  • Non-GLP Toxicology
  • Safety Pharmacology

Oncology

In Vivo Services

  • Breast Cancer Preclinical Models
  • Cell Line Derived Xenograft Models
  • Custom Tumor Model Development
  • Immuno-Oncology Models
  • MuScreen
  • Orthotopic and Bioluminescent Models
  • Patient-Derived Xenograft Models (HuPrime/HuKemia)
  • Prostate Cancer Preclinical Models
  • Radiation Therapy
  • Syngeneic Tumor Models

In Vitro Services

  • Cell Based Screening
    • CrownSyn
  • Cell Line Panels
  • Flow Cytometry Platform
  • Immuno-Oncology
  • OmniScreen Cell Based Screening Service
  • Organoids
  • PDX-Derived Cell Lines

Organoids

  • Organoid and Immune Cell Co-Culture

Ex Vivo Services

  • 3D Assays
  • Tumor Microarrays

Immuno-Oncology

  • CAR-T Cell Therapy Models
    • Cell Line Derived Xenografts Targeting CD19
    • PDX
  • Humanized Models
    • Hematopoietic Stem Cell (HSC)-PDX
    • MiXeno
  • Human Target Knock-In Models
    • HuGEMM
    • HuCELL
  • Murine Immunity Models and Services
    • Tumor Homograft Models
    • Syngeneic tumor models
    • MuScreen

Oncology

Translational Oncology

  • 1+1 Mouse Trial
  • Biomarkers of Response (HuMark)
  • Mouse Clinical Trials (HuTrial)
  • Signatures of Response (HuSignature)

Biomarker Services

  • Flow Cytometry Platform
  • Histology and Digital Pathology Platform

Pharmacology and Bioanalytical Services

  • ADME & Physicochem
  • Bioanalysis Studies
  • FACS Platform
  • In Vivo PK/PD
  • NHP Immuno-Safety
  • Structural Biology
  • Target Validation

Oncology Databases

  • HuBase
  • MuBase
  • OncoExpress
  • XenoBase

Follow Us

  • © 2020 Crown Bioscience Inc.   
  • Contact Us
  • Site Map
  • Terms of Use
  • Ordering Terms
  • Privacy Policy